New Alzheimer's drug combo faces safety test
NCT ID NCT07212062
Summary
This study aims to check if a new drug combination called X/T+X-EC is safe and tolerable for people with Alzheimer's disease who are already being treated with the medication lecanemab. It will involve 60 participants aged 60-85 over 32 weeks. Participants will be randomly assigned to receive either the new drug combination or a placebo, while continuing their standard lecanemab treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMERS DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.